Top News
Regeneron Pharmaceuticals acquires 23andMe’s Personal Genome Service, Total Health and Research Services businesses, and Biobank and related assets for $256 million at bankruptcy auction, beating out a bid from co-founder and former CEO…
Continue Reading
What You Should Know:
– 23andMe, a human genetics and biotechnology company, has announced its decision to initiate voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri.
– The bankruptcy…
Continue Reading
Human genetics and biotechnology company 23andMe has filed for Chapter 11 proceedings in the U.S. Bankruptcy Court for the Eastern District of Missouri to facilitate a sales process. In a press release, the company said…
Continue Reading
What You Should Know:
– Frederick Health (Frederick, MD) recently launched a first-of-its-kind precision medicine integration that enhances their decision support capabilities with intuitive recommendations that are tailored to the individual patient and their cancer’s specific…
Continue Reading
Specialty care platform Lantern announced a partnership with digital substance use management platform Pelago to provide Lantern’s clients with access to personalized substance use disorder treatment. Starting next year, Lantern clients will gain access to…
Continue Reading
What You Should Know:
– Today, leading US health systems, including Advocate Health, CommonSpirit Health, Henry Ford Health, Northwell Health, Providence, and Trinity Health, announce the Truveta Genome Project, an innovative collaboration to generate genetic data on…
Continue Reading
Dozens of health systems representing millions of patients across the United States are collaborating with the Truveta Genome Project, Regeneron Genetics Center and genomic sequencing company Illumina to sequence the exomes of their first…
Continue Reading
What You Should Know:
– Baylor Genetics, a clinical diagnostic laboratory specializing in genetic testing, announced its integration with Aura, the specialty diagnostics suite from Epic EHR.
– The integration will enable healthcare organizations using Epic…
Continue Reading
What You Should Know:
– WellRX, the parent company of preventative healthcare brands ReviveRX and Ways2Well, has acquired Bioreach, a cutting-edge bloodwork and genetics laboratory.
– The strategic acquisition brings advanced diagnostic capabilities in-house, allowing WellRX…
Continue Reading
Patients with rare diseases often experience prolonged diagnostic delays. Ordering appropriate genetic tests is crucial yet challenging, especially for general pediatricians without genetic expertise. Recent American College of Medical Genetics (ACMG) guidelines embrace early…
Continue Reading
